Pernas, S., Sanfeliu, E., Villacampa, G., Salvador, J., Perelló, A., González, X., . . . Ciruelos, E. Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapy. Nature Portfolio.
Chicago Style (17th ed.) CitationPernas, Sonia, et al. Palbociclib and Letrozole for Hormone Receptor-positive HER2-negative Breast Cancer with Residual Disease After Neoadjuvant Chemotherapy. Nature Portfolio.
MLA (9th ed.) CitationPernas, Sonia, et al. Palbociclib and Letrozole for Hormone Receptor-positive HER2-negative Breast Cancer with Residual Disease After Neoadjuvant Chemotherapy. Nature Portfolio.
Warning: These citations may not always be 100% accurate.